C4 Therapeutics, Inc.·4

Jan 3, 4:10 PM ET

GROGAN DONNA ROY 4

4 · C4 Therapeutics, Inc. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Transactions
  • Award

    Common Stock

    2024-01-02$6.52/sh+2,108$13,74421,935 total
Footnotes (2)
  • [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
  • [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2024.

Documents

1 file
  • 4
    wk-form4_1704316184.xmlPrimary

    FORM 4